The previous page is sending you to http://www.marketwatch.com/story/sagent-pharmaceuticals-announces-launch-of-irinotecan-hydrochloride-injection-in-single-dose-vials-2012-05-17.

 If you do not want to visit that page, you can return to the previous page.